ENANTA PHARMACEUTICALS INC Annual Costs and Expenses in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Enanta Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from 2014 to 2023.
  • Enanta Pharmaceuticals Inc Costs and Expenses for the quarter ending June 30, 2024 was $42.2M, a 24.2% decline year-over-year.
  • Enanta Pharmaceuticals Inc Costs and Expenses for the twelve months ending June 30, 2024 was $195M, a 8.88% decline year-over-year.
  • Enanta Pharmaceuticals Inc annual Costs and Expenses for 2023 was $216M, a 3.05% increase from 2022.
  • Enanta Pharmaceuticals Inc annual Costs and Expenses for 2022 was $210M, a 1.63% increase from 2021.
  • Enanta Pharmaceuticals Inc annual Costs and Expenses for 2021 was $207M, a 25.9% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $216M +$6.41M +3.05% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-22
2022 $210M +$3.36M +1.63% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-22
2021 $207M +$42.5M +25.9% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-22
2020 $164M -$4.35M -2.58% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-23
2019 $168M +$50.2M +42.4% Oct 1, 2018 Sep 30, 2019 10-K 2021-11-24
2018 $118M +$40.1M +51.3% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-25
2017 $78.2M +$20.8M +36.2% Oct 1, 2016 Sep 30, 2017 10-K 2019-11-27
2016 $57.4M +$20.7M +56.3% Oct 1, 2015 Sep 30, 2016 10-K 2018-11-29
2015 $36.7M +$7.98M +27.7% Oct 1, 2014 Sep 30, 2015 10-K 2017-12-11
2014 $28.8M Oct 1, 2013 Sep 30, 2014 10-K 2016-12-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.